317 related articles for article (PubMed ID: 22088371)
21. RIZ1: a potential tumor suppressor in glioma.
Zhang C; Zhu Q; He H; Jiang L; Qiang Q; Hu L; Hu G; Jiang Y; Ding X; Lu Y
BMC Cancer; 2015 Dec; 15():990. PubMed ID: 26690953
[TBL] [Abstract][Full Text] [Related]
22. Co-expression of mitosis-regulating genes contributes to malignant progression and prognosis in oligodendrogliomas.
Liu Y; Hu H; Zhang C; Wang H; Zhang W; Wang Z; Li M; Zhang W; Zhou D; Jiang T
Oncotarget; 2015 Nov; 6(35):38257-69. PubMed ID: 26468983
[TBL] [Abstract][Full Text] [Related]
23. Suppression of Rac activity induces apoptosis of human glioma cells but not normal human astrocytes.
Senger DL; Tudan C; Guiot MC; Mazzoni IE; Molenkamp G; LeBlanc R; Antel J; Olivier A; Snipes GJ; Kaplan DR
Cancer Res; 2002 Apr; 62(7):2131-40. PubMed ID: 11929835
[TBL] [Abstract][Full Text] [Related]
24. MiR-16-5p is frequently down-regulated in astrocytic gliomas and modulates glioma cell proliferation, apoptosis and response to cytotoxic therapy.
Krell A; Wolter M; Stojcheva N; Hertler C; Liesenberg F; Zapatka M; Weller M; Malzkorn B; Reifenberger G
Neuropathol Appl Neurobiol; 2019 Aug; 45(5):441-458. PubMed ID: 30548945
[TBL] [Abstract][Full Text] [Related]
25. Insights into the clinical value of cyclin-dependent kinase 5 in glioma: a retrospective study.
Yushan R; Wenjie C; Suning H; Yiwu D; Tengfei Z; Madushi WM; Feifei L; Changwen Z; Xin W; Roodrajeetsing G; Zuyun L; Gang C
World J Surg Oncol; 2015 Jul; 13():223. PubMed ID: 26205145
[TBL] [Abstract][Full Text] [Related]
26. Epidermal Growth Factor Receptor and Ki-67 Expression in Canine Gliomas.
Fraser AR; Bacci B; le Chevoir MA; Long SN
Vet Pathol; 2016 Nov; 53(6):1131-1137. PubMed ID: 27154542
[TBL] [Abstract][Full Text] [Related]
27. Microvascular proliferation of brain metastases mimics glioblastomas in squash cytology.
Gi T; Sato Y; Tokumitsu T; Yamashita A; Moriguchi-Goto S; Takeshima H; Sato S; Asada Y
Cytopathology; 2017 Jun; 28(3):228-234. PubMed ID: 27995658
[TBL] [Abstract][Full Text] [Related]
28. Correlation of apparent diffusion coefficient with Ki-67 in the diagnosis of gliomas.
Yin Y; Tong D; Liu XY; Yuan TT; Yan YZ; Ma Y; Zhao R
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Oct; 34(5):503-8. PubMed ID: 23134828
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-210 overexpression predicts poorer prognosis in glioma patients.
Lai NS; Dong QS; Ding H; Miao ZL; Lin YC
J Clin Neurosci; 2014 May; 21(5):755-60. PubMed ID: 24382515
[TBL] [Abstract][Full Text] [Related]
30. Tissue thioredoxin reductase-1 expression in astrocytomas of different grades.
Esen H; Erdi F; Kaya B; Feyzioglu B; Keskin F; Demir LS
J Neurooncol; 2015 Feb; 121(3):451-8. PubMed ID: 25391969
[TBL] [Abstract][Full Text] [Related]
31. MiR-210 up-regulation inhibits proliferation and induces apoptosis in glioma cells by targeting SIN3A.
Shang C; Hong Y; Guo Y; Liu YH; Xue YX
Med Sci Monit; 2014 Dec; 20():2571-7. PubMed ID: 25481483
[TBL] [Abstract][Full Text] [Related]
32. [CDK1 expression and effects of CDK1 silencing on the malignant phenotype of glioma cells].
Chen H; Huang Q; Zhai DZ; Dong J; Wang AD; Lan Q
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):484-8. PubMed ID: 18069625
[TBL] [Abstract][Full Text] [Related]
33. Survivin expression and its relation with proliferation, apoptosis, and angiogenesis in brain gliomas.
Zhen HN; Zhang X; Hu PZ; Yang TT; Fei Z; Zhang JN; Fu LA; He XS; Ma FC; Wang XL
Cancer; 2005 Dec; 104(12):2775-83. PubMed ID: 16284993
[TBL] [Abstract][Full Text] [Related]
34. Expression of Ki-67, topoisomerase IIalpha and c-MYC in astrocytic tumors: correlation with the histopathological grade and proliferative status.
Faria MH; Gonçalves BP; do Patrocínio RM; de Moraes-Filho MO; Rabenhorst SH
Neuropathology; 2006 Dec; 26(6):519-27. PubMed ID: 17203587
[TBL] [Abstract][Full Text] [Related]
35. Subtyping of gliomas of various WHO grades by the application of immunohistochemistry.
Popova SN; Bergqvist M; Dimberg A; Edqvist PH; Ekman S; Hesselager G; Ponten F; Smits A; Sooman L; Alafuzoff I
Histopathology; 2014 Feb; 64(3):365-79. PubMed ID: 24410805
[TBL] [Abstract][Full Text] [Related]
36. [Inhibitory effect of antisense and dominant-negative AKT2 constructs on proliferation of glioma cell line TJ905].
Kang CS; Pu PY; Li J; Wang GX
Ai Zheng; 2004 Nov; 23(11):1267-72. PubMed ID: 15522171
[TBL] [Abstract][Full Text] [Related]
37. miR-340 inhibits glioblastoma cell proliferation by suppressing CDK6, cyclin-D1 and cyclin-D2.
Li X; Gong X; Chen J; Zhang J; Sun J; Guo M
Biochem Biophys Res Commun; 2015 May; 460(3):670-7. PubMed ID: 25817794
[TBL] [Abstract][Full Text] [Related]
38. [Study on effects of microRNA-21 antisense oligonucleotide in vivo and in vitro on bionomics of human cervical squamous carcinoma cell lines SiHa].
Wang XM; Xu J; Cheng ZQ; Peng QZ; Hu JT; Gao LK; Zhang SF; Jin HT
Zhonghua Bing Li Xue Za Zhi; 2012 Apr; 41(4):254-9. PubMed ID: 22800522
[TBL] [Abstract][Full Text] [Related]
39. Expression of p27KIP1 in human gliomas: relationship between tumor grade, proliferation index, and patient survival.
Zagzag D; Blanco C; Friedlander DR; Miller DC; Newcomb EW
Hum Pathol; 2003 Jan; 34(1):48-53. PubMed ID: 12605366
[TBL] [Abstract][Full Text] [Related]
40. [Research on relationship of survivin gene expression with malignant proliferation and apoptosis of brain glioma].
Zhen HN; Zhang X; Hu PZ; Fu LA; Yang TT; Ma FC; Wang XL; Liang JW
Zhonghua Wai Ke Za Zhi; 2005 Jul; 43(13):885-8. PubMed ID: 16083611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
